Medication info
Brivaracetam 100 mg Tablet

Brivaracetam 100 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Brivaracetam›100mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
Olive green oval film-coated tablet
Packaging
60 tablets/PTP [10 tablets/PTP X 6]
Approval status
Active

MFDS item code 202502747 · Approved 2025.10.24

Summary

Main use
Adjunctive treatment of partial-onset seizures in patients with epilepsy aged 16 years and older
Who takes it
Adults
Adult dose
This product is taken twice daily. The recommended initial dose is 25mg or 50mg per dose, based on the healthcare professional's assessment of potential adverse effects relative to seizure reduction. Based on clinical response and tolerability, the dose may be increased or decreased from 50mg daily [25mg twice daily] to 200mg daily [100mg twice daily]. Take this product as a whole film-coated tablet with water. It may be taken with or without food. If you miss one or more doses, take one dose as soon as you remember, then take the next dose at the next scheduled morning or evening time. If you wish to discontinue this product, gradually reduce the dose by 50mg daily at 1-week intervals. After taking 50mg daily for 1 week, a dose of 20mg daily is recommended during the final week (see section '1. Warnings'). Older adults (65 years or older): No dosage adjustment is necessary for older adults. Clinical experience in older patients aged 65 years or older is limited. Renal impairment: No dosage adjustment is necessary for patients with renal impairment. This product is not recommended for patients with end-stage renal disease undergoing hemodialysis. Hepatic impairment: Exposure to this product is increased in patients with hepatic impairment. An initial dose of 50mg daily [25mg twice daily] is recommended for patients with hepatic impairment, and a maximum dose of 150mg daily [75mg twice daily] is recommended.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive treatment of partial-onset seizures in patients with epilepsy aged 16 years and older

  • Secondary generalized seizures
  • partial seizures
View approved original text

This medication is used as an adjunctive therapy for the treatment of partial seizures in patients with epilepsy aged 16 and older. It is particularly effective in cases where secondary generalized seizures are present or absent. In other words, it helps control various types of seizures and improves the patient's symptoms. This drug reduces the frequency of periodic seizures and contributes to improving the quality of daily life. Therefore, it plays an important role in epilepsy management and is used to assist in overall neurological stabilization.

How to take

Adult dose

This product is taken twice daily. The recommended initial dose is 25mg or 50mg per dose, based on the healthcare professional's assessment of potential adverse effects relative to seizure reduction. Based on clinical response and tolerability, the dose may be increased or decreased from 50mg daily [25mg twice daily] to 200mg daily [100mg twice daily]. Take this product as a whole film-coated tablet with water. It may be taken with or without food. If you miss one or more doses, take one dose as soon as you remember, then take the next dose at the next scheduled morning or evening time. If you wish to discontinue this product, gradually reduce the dose by 50mg daily at 1-week intervals. After taking 50mg daily for 1 week, a dose of 20mg daily is recommended during the final week (see section '1. Warnings'). Older adults (65 years or older): No dosage adjustment is necessary for older adults. Clinical experience in older patients aged 65 years or older is limited. Renal impairment: No dosage adjustment is necessary for patients with renal impairment. This product is not recommended for patients with end-stage renal disease undergoing hemodialysis. Hepatic impairment: Exposure to this product is increased in patients with hepatic impairment. An initial dose of 50mg daily [25mg twice daily] is recommended for patients with hepatic impairment, and a maximum dose of 150mg daily [75mg twice daily] is recommended.

Precautions

This drug may cause serious mental health issues such as suicidal ideation or behavior, so patients and caregivers should carefully monitor for these symptoms. This medication can cause central nervous system symptoms such as drowsiness, fatigue, and dizziness, especially when starting treatment. Discontinuing this medication suddenly may increase the frequency of seizures, thus it should be tapered off according to a doctor's instructions. This medication should not be taken by individuals with an allergy to any of its components or specific genetic lactose metabolism disorders. Patients with liver function problems may require dose adjustments while using this medication, so they must consult their healthcare provider. If a skin rash or severe allergic reaction occurs during use, inform a doctor immediately and discontinue the medication if necessary. This drug may interact with other antiepileptic medications, so be sure to inform healthcare providers about any other medications being taken. It is advisable to avoid alcohol consumption as it may exacerbate the side effects of this drug. Women who are pregnant or planning to become pregnant should consult their doctor about the use of this medication, and caution is also advised for nursing mothers. Children under 16 should not take this medication, as safety and efficacy have not been adequately established. This drug can cause drowsiness and dizziness, so care should be taken when driving or operating machinery. In the event of overdose, symptoms such as severe drowsiness, dizziness, and anxiety may occur, and if suspected, immediate medical attention is necessary. Keep this medication out of the reach of children and avoid transferring it to other containers.

Side effects

  • suicidal thoughts
  • suicidal behavior
  • drowsiness
  • fatigue
  • dizziness
  • coordination movement disorder
  • influenza
  • type I hypersensitivity reaction
  • neutropenia
  • decreased appetite
Show 14 more
  • depression
  • anxiety
  • irritability
  • insomnia
  • psychotic symptoms
  • aggression
  • restlessness
  • seizures
  • vertigo
  • upper respiratory infection
  • cough
  • nausea
  • vomiting
  • constipation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain its efficacy and safety for a long time.

Appearance and packaging

Appearance

Olive green oval film-coated tablet

Package unit

60 tablets/PTP [10 tablets/PTP X 6]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.